与囊性纤维化斗争中的英雄 | 盖茨书评

文章预览

In 1999, a Microsoft colleague named Paul Flessner approached me with a personal request: Would I be willing to help fund the development of new drugs for cystic fibrosis, an awful lung disease that affects about 30,000 people—including more than 10,000 children—in the U.S. and about 70,000 people worldwide? 1999年，一个叫保罗·弗莱斯尼尔的微软同事向我提出了一项个人请求：我是否愿意帮助资助开发针对囊肿性纤维化（CF）的新药？这是一种可怕的肺病，影响着约3万美国人（其中超过1万是儿童）和全世界大约7万人。 Ten years after the discovery of the gene implicated in CF, researchers still had not produced any medical breakthroughs for CF patients, and Paul was concerned that time was running short for his sons. So he asked me to support an effort by a small startup called Aurora Biosciences to screen ………………………………